Britta Eichler
MD
Director, Oncology Drug Development
👥Biography 个人简介
Dr. Britta Eichler specializes in early-phase oncology drug development with a focus on RAS pathway inhibitors. She is actively involved in clinical trials evaluating SOS1 inhibitors such as BI 1701963 in combination with KRAS G12C inhibitors. Her work explores rational combinations to prevent adaptive resistance through upstream RAS-GEF signaling that reactivates KRAS signaling under G12C inhibitor pressure.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Britta Eichler 的研究动态
Follow Britta Eichler's research updates
留下邮箱，当我们发布与 Britta Eichler（Brigham and Women's Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment